<DOC>
	<DOCNO>NCT02086045</DOCNO>
	<brief_summary>To evaluate safety , performance efficacy Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System ( BCSS ) patient single de novo native coronary artery lesion designate target lesion one non-target lesion locate separate epicardial vessel .</brief_summary>
	<brief_title>Elixir Medical Clinical Evaluation DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patient must least 18 year age 35patient subset , patient must age 50 Patient able verbally confirm understand risk , benefit treatment alternative receive DESolve Nx Novolimus Eluting BCSS he/she provide write informed consent , approve appropriate Ethics Committee respective clinical site , prior clinical study related procedure Patient must evidence myocardial ischemia ( e.g. , stable unstable angina , silent ischemia , positive functional study electrocardiogram ( ECG ) change consistent ischemia ) Patient must acceptable candidate coronary artery bypass graft ( CABG ) surgery Patient must agree undergo clinical study require followup visit , angiogram , applicable , IVUS , OCT , MSCT coronary vasomotion test Patient must agree participate clinical study period two year follow index procedure Angiographic Target lesion must locate native coronary artery nominal vessel diameter 2.75 3.5 mm assess online QCA Target lesion must measure ≤ 14 mm length Target lesion must major artery branch visually estimate stenosis ≥ 50 % &lt; 90 % TIMI flow ≥ 1 Percutaneous intervention lesion target vessel : 1 . Not part clinical investigation 2 . ≥ 6 month prior study index procedure 3 . ≥ 9 month study index procedure ( plan ) 4 . Previous intervention distal &gt; 10mm target lesion Patient know diagnosis acute myocardial infarction ( AMI ) within 72 hour precede index procedure CK CKMB return within normal limit time procedure Patient currently experience clinical symptom consistent AMI Patient require use rotablator intervention index procedure Patient current unstable arrhythmias Patient known leave ventricular ejection fraction ( LVEF ) &lt; 30 % Patient receive heart transplant organ transplant wait list organ transplant Patient receiving schedule receive chemotherapy malignancy within 30 day prior procedure Patient receive immunosuppression therapy know immunosuppressive autoimmune disease ( e.g . human immunodeficiency virus , systemic lupus erythematosus etc . ) Patient receive chronic anticoagulation therapy ( e.g. , heparin , coumadin ) stop restart accord local hospital standard procedure . Patient known hypersensitivity contraindication aspirin , heparin bivalirudin , clopidogrel ticlopidine , Novolimus , PLLA polymer contrast sensitivity adequately premedicated Elective surgery plan within first 6 month procedure require discontinue either aspirin clopidogrel Patient platelet count &lt; 100,000 cells/mm3 &gt; 700,000 cells/mm3 , WBC &lt; 3,000 cells/mm3 , document suspect liver disease . Patient known renal insufficiency ( e.g. , serum creatinine level 2.5 mg/dL , patient dialysis ) Patient history bleed diathesis coagulopathy refuse blood transfusion Patient cerebrovascular accident ( CVA ) transient ischemic neurological attack ( TIA ) within past six month Patient significant GI urinary bleed within past six month Patient extensive peripheral vascular disease precludes safe 6 French sheath insertion Patient medical illness ( e.g. , cancer congestive heart failure ) know history substance abuse ( alcohol , cocaine , heroin etc . ) may cause noncompliance clinical study plan , confound data interpretation associate limited life expectancy ( i.e. , less one year ) Patient already participate another clinical study Women childbearing potential undergone surgical sterilization postmenopausal ( define amenorrheic least one year ) well woman pregnant nursing Patient unable give consent , legally incompetent , institutionalized virtue order issue court authority Angiographic Exclusion Criteria Target lesion ( ) meet follow criterion : 1 . Aortoostial location 2 . Left main location 3 . Located within 5 mm origin LAD LCX 4 . Located within arterial saphenous vein graft distal diseased arterial saphenous vein graft 5 . Lesion involve side branch &gt; 2mm diameter bifurcation 6 . Previous placement scaffold proximal within 10 mm target lesion 7 . Total occlusion ( TIMI flow 0 ) , TIMI flow &lt; 1 8 . Excessive tortuosity proximal within lesion 9 . Angulation ( ≥ 45o ) proximal within lesion 10 . Calcification moderate heavy 11 . Previous intervention restenosis The target vessel contain visible thrombus Another clinically significant lesion ( &gt; 40 % ) locate major epicardial vessel target lesion Patient high probability procedure predilatation scaffolding ( necessary ) postdilatation require time index procedure treatment target vessel ( e.g . atherectomy , cut balloon brachytherapy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Coronary artery disease</keyword>
</DOC>